Divi's Laboratories Q2 results: standalone profit up 64% to Rs 1,140 crore, revenue Rs 3,647 crore
Divi's Laboratories Q2 results: standalone profit after tax up 64% to Rs 1,140 crore; revenue from operations rose to Rs 3,647 crore.
Divi’s Laboratories reported standalone profit after tax of Rs 1,140 crore for the quarter ended September 30, 2026 (Q2 FY27), up 64% from Rs 696 crore a year earlier, according to its results filed with NSE and BSE on November 7, 2026. The Divi’s Laboratories Q2 results show standalone revenue from operations of Rs 3,647 crore, up 37%.
Divi’s Laboratories Q2 results: key numbers
The figures below are standalone and in Rs crore, taken from the company’s filing.
| Measure (Rs crore) | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 3,647 | 2,660 | 37% |
| Profit before tax | 1,520 | 920 | 65% |
| Profit after tax | 1,140 | 696 | 64% |
| Earnings per share (Rs) | 42.97 | 26.24 | 64% |
Compared with the April-June quarter, revenue rose 23% from Rs 2,974 crore and profit after tax rose from Rs 891 crore. For the half year, standalone profit after tax was Rs 2,031 crore against Rs 1,253 crore a year earlier.
What changed in costs and income
Cost of materials consumed nearly doubled to Rs 1,803 crore from Rs 907 crore, in line with higher production and sales. The company also built up finished goods and work in progress: the inventory line was a Rs 630 crore credit this quarter, against a Rs 144 crore charge a year ago.
Employee costs were Rs 428 crore, up from Rs 344 crore. Other income fell to Rs 88 crore from Rs 146 crore. There were no exceptional items in the quarter. The filing does not itself explain what drove demand; the company’s press release accompanies it.
Consolidated view and cash flow
Consolidated revenue from operations was Rs 3,676 crore, up from Rs 2,715 crore a year ago, a rise of about 35%.
Inventories rose to Rs 5,325 crore from Rs 3,711 crore at March 31, 2026. As a result, standalone net cash from operating activities for the half year was Rs 370 crore, against Rs 1,640 crore a year earlier.
What to watch next
In our view, the pace at which the higher inventory converts into sales and cash is the number to follow in the next quarter. Read more in our results news section.
Frequently asked questions
Are these Divi's Laboratories figures standalone or consolidated?
The profit and cost figures in this article are standalone. The company also filed consolidated results, which showed revenue from operations of Rs 3,676 crore for the quarter.
This article is a summary for information only and is not investment advice. Figures are as reported by the sources above; please verify with the original filing or report before making any decision.
More Results News
See all →- Tata Steel Q2 results: consolidated profit after tax rises 16% to Rs 3,700 crore as EBITDA grows 17%
- Tata Chemicals Q2 results: consolidated loss of Rs 50 crore as UK gas costs and lower realisations bite
- Aurobindo Pharma declares Rs 7 interim dividend as Q2 net profit rises 32.5% to Rs 1,124 crore
- Honasa Consumer Q2 results: revenue up 36% to Rs 731 crore, EBITDA nearly doubles to Rs 93 crore
- Coromandel International Q2 results: profit falls 33% on fertiliser margin pressure